The main aim of developing Biobanking at ¹û¶³Ó°Ôº is to maximise the value of data and biospecimen repositories across all campuses. Biobanking is now heavily relied upon worldwide for advancing research into aÌýcomprehensive variety of health problems and to develop new ideas, technology and knowledge. Access to biorepositories and associated data is crucial to ongoing biomedical research.
It is vital for large and small sample collections and data to be fully appreciated, ensuring the robust, accurate management of tissue and data repositories. To achieve this in a rationalized model, the full potential of these sample and data sets in the development of new translational research ideas and advancement of personalised medicine can be realised, not only by those at ¹û¶³Ó°Ôº but by the wider research community.
Developing infrastructure for Biobanking at ¹û¶³Ó°Ôº will help maximise, for patient benefit, the value of data and biospecimen repositories across all campuses. Patients' samples with pseudoanonymised data are crucial for the development of biomedical research, particularly translational research. ¹û¶³Ó°Ôº Biobanking information around governance and safe use of human tissue for patient benefit and research is centralised through this website.
¹û¶³Ó°Ôº Biobanks
There are nineÌý¹û¶³Ó°Ôº and associated NHS Trust HTA Licenses. These are:
- HTA Licence 11016 - Royal Free Hospital
- HTA Licence 12055 - ¹û¶³Ó°Ôº Cancer Institute
- HTA Licence 12120 - ¹û¶³Ó°Ôº Anatomy Licence
- HTA Licence 12161 - ¹û¶³Ó°Ôº Ear Institute
- HTA Licence 12177 - ¹û¶³Ó°Ôº Institute of Ophthalmology
- HTA Licence 12198 - ¹û¶³Ó°Ôº Queen Square Institute of Neurology
- HTA Licence 12220 - ¹û¶³Ó°Ôº Great Ormond Street Institute of Child Health
- HTA Licence 12277 - ¹û¶³Ó°Ôº Eastman Dental Institute
- HTA Licence 12620 - ¹û¶³Ó°Ôº Pathology Collections and Public Display